2013-06-19 14:00 Akademiska sjukhuset Insatser i rätt tid och från rätt aktör kan hjälpa långtidssjukskrivna kvinnor tillbaka...
Håkan Gartell appointed acting CEO of A+ Science
A+ Science2010-12-17 10:58
Agneta Franksson, former CEO of CRO company A+ Science, has decided to resign. Håkan Gartell has been appointed acting CEO.
Håkan has a bachelor's degree in economics and human geography and has previously been CEO of Vita Nova Ventures AB (publ), Kapitalkraft in Sweden AB, Stock Invest, Civic Fondkommission, Banco Fonder, Aktiespararnas Service AB and stock market editor at Dagens Industri.
Board of director assignments include chairman of Stock Invest, ESMA Fraser, Kindwalls Bil AB (publ) and Phir AB. Board member of Havsfrun Investment AB (publ) and Taurus Energy AB (publ).
The recruitment of a new CEO will begin immediately.
For more information:
Akbar Seddigh, chairman of the board A+ Science Holding, +46 31 703 18 50
Håkan Gartell acting CEO A+ Science, +46 705 14 13 66
- Medicinsk forskning